克劳丁18.2通过激活MCM2/5/5促进胃癌的扩散
Bowen Zheng1,2,3, Miao Fu1, Fanzhuoran Lou1
1Department of Oncology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361004, Fujian, China.
Scientific reports
|February 23, 2026
概括
佐尔贝图西马布加化疗改善了胃癌患者的无进展生存率,这些患者的CLDN18.2阳性. 在临床前模型中,CLDN18.2向还抑制了瘤生长,并影响了细胞循环中的关键蛋白质.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 分子生物学分子生物学
背景情况:
- 胃/胃食道结 (GC/GEJ) 腺癌仍然是一个重大的健康挑战.
- 克劳丁18.2 (CLDN18.2) 是GC/GEJ治疗中的新兴标.
- HER2阴性状态是CLDN18.2向治疗选择的关键特征.
研究的目的:
- 为了评估Zolbetuximab与化学疗法结合在CLDN18.2-阳性GC/GEJ中的疗效.
- 为了研究CLDN18.2表达在GC中的预后意义.
- 探索CLDN18.2对GC细胞生长和分子通路的临床前影响.
主要方法:
- 对III期SPOTLIGHT和GLOW试验的综合分析 (n=1072).
- 在GC队列中检测到CLDN18.2的免疫组织化学检测 (n=92).
- 在体外和体外研究涉及CLDN18.2在GC细胞中的敲除.
主要成果:
- 佐尔贝图西马布加化疗显著改善了无进展生存期 (PFS) 与安慰剂相比 (HR=0.72).
- CLDN18.2阳性与晚期,淋巴结转移和较短的整体存活期 (OS) (HR=1.728) 相相关.
- CLDN18.2 knockdown 抑制了瘤生长,降低了 MCM 蛋白质表达和 ERK/CDK 酸化.
结论:
- 索尔贝图西马布联合治疗为CLDN18.2-阳性GC/GEJ患者提供了一个新的选择.
- CLDN18.2是GC的验证治疗标和预后生物标志物.
- 准CLDN18.2显示出通过分子途径调制抑制GC进展的希望.
相关概念视频
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Mucosal Barrier of the Stomach
2.5K
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
2.5K
Cadherins in Tissue Organization
4.3K
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Cell Sorting During Development
Cell sorting plays an...
4.3K
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.5K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.5K
Induced Pluripotent Stem Cells
5.7K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.7K

